Let's talk medical research

Recruiting patients for clinical trials is a common challenge for study sponsors conducting research. For this reason, it is often a wise strategy to work with an agency that specializes in outreach. These agencies excel at helping sponsors achieve their research goals within defined timelines and budgets.

Multiple sclerosis, often shortened to MS, is an autoimmune disorder that causes the body to attack the central nervous system. It is estimated that a million adults in the United States are living with this condition, and symptoms can include a variety of phenomena such as numbness, tingling, speech difficulties, tremors, vision issues, balance problems, and pain, all at varying degrees of ...

Volunteers play a vital role in clinical trials; nevertheless, the participant experience is often suboptimal. In an interview with Newsweek, Paul Wicks, former VP of Innovation at PatientsLikeMe once remarked, “Sometimes, it’s almost as bad as dealing with Comcast or the worst airline.” When patients are faced with overwhelming paperwork, inconvenient appointment times, and tedious symptom ...

Antidote’s mission is to connect patients with medical research so medical breakthroughs can take place. A key part of our strategy is partnering with nonprofits and patient advocacy groups. We provide our clinical trial matching technology, Antidote Match, at no cost to these organizations, to help patients and caregivers discover new research opportunities and connect to clinical trials quickly ...

An estimated 1 in 10,000 people have primary sclerosing cholangitis (PSC), a condition that impacts the bile ducts that run between the liver, the gallbladder, and the small intestine. The liver produces bile to transport to the gallbladder for storage, or to the small intestine where it aids in the digestion of fats. In the case of PSC, there is inflammation in the bile ducts (cholangitis) which ...

As we move into 2024, we’d like to take a moment to highlight some of the significant achievements from the past year. Throughout 2023, we were able to reach more patients, work with more sponsors, and expand our business offerings in meaningful ways — and the impact we had serves as a great reminder of why we do what we do. In the infographic below, we’re delving deeper into the statistics that ...

One of the most important results of the work we do at Antidote is directly impacting the lives of patients — and getting to hear their stories is a constant reminder of why we do what we do.

Though clinical trial patient recruitment is an integral part of the medical research process, it is often one of the most difficult aspects of conducting a study. There are various reasons for this challenge, and among them is the widespread existence of misconceptions about participating in research that many patients may see as a barrier to entry.

While the primary goal of clinical trials is to help identify potential new treatments that improve people's health and save lives, it's the unfortunate truth that the patient experience is often not prioritized. This discrepancy becomes evident in industry findings, highlighting a substantial disparity between the services patients want from pharmaceutical companies compared to what they ...

The latest episode of Antidote’s quarterly podcast series Talk of the Towne is available now! Talk of the Towne is focused on bridging the gap between clinical discussion and patient centricity, hosted by Antidote’s Senior Clinical Informatics Manager, Dr. Richard Towne, PharmD.